Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-depth Studies of Glucagon Resistance on Hepatic Glucose, Fatty Acid and Triglyceride Kinetics and Generation of Toxic Lipid Intermediates in NAFLD and NASH.

NCT04042142 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT04042142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04042142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-depth Studies of Glucagon Resistance on Hepatic Glucose, Fatty Acid and Triglyceride Kinetics and Generation of Toxic Lipid Intermediates in NAFLD and NASH.
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Completed
Start date
October 5, 2019
Completion date
August 18, 2022
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose metabolism disorders, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis